US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist

9.830
+1.267+14.79%

Close Feb 26 16:00 ET

10.000
+0.170+1.73%

Post 16:20 ET

82.73MMarket Cap-0.70P/E (TTM)

Karyopharm Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Karyopharm Therapeutics Q4 2024 Earnings Date

Currency：USDFeb 19, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	35.67M	30.54M	-5.13M
Miss Est.	+5.71%	-9.50%	-14.39%
EPS	-4.05	-3.60	+0.45
Beat Est.	+25.00%	+33.33%	+11.11%

Analyst Rating

Strong Buy

Feb 26, 2025

Karyopharm Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 36.987M	--
--	2025/Q1	-- / 34.816M	--
Feb 19, 2025	2024/Q4	30.542M / 35.674M	--
Nov 5, 2024	2024/Q3	38.783M / 37.924M	--
Aug 6, 2024	2024/Q2	42.786M / 36.213M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 36.987M--

--2025/Q1-- / 34.816M--

Feb 19, 20252024/Q430.542M / 35.674M--

Nov 5, 20242024/Q338.783M / 37.924M--

Aug 6, 20242024/Q242.786M / 36.213M--

Unlock Free Earnings Estimates

Open Account

Karyopharm Therapeutics Earnings Reports

Karyopharm Therapeutics | 10-K: FY2024 Annual Report

Feb 19 07:41 ET

Karyopharm Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 5, 2024 07:51 ET

Karyopharm Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 6, 2024 07:43 ET

Karyopharm Therapeutics | 10-Q: Q1 2024 Earnings Report

May 8, 2024 17:18 ET